GlassScriptPhysician profile
Sam Sanandaji
NPI 1063460616
$2,824.90
in general payments reported to CMS, 2019-2025
38 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $260 · 2021: $220 · 2022: $203 · 2023: $698 · 2024: $537 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,771.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $311.96 | 2021-2025 | Repatha, Krystexxa, Repatha |
| Paratek Pharmaceuticals, INC. | $209.05 | 2020-2024 | Nuzyra |
| Orthofix Medical, INC. | $196.78 | 2025 | Physio-Stim, Tl-Hex Truelok Hexapod System |
| Bioventus LLC | $174.01 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Inari Medical, INC. | $169.59 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $153.61 | 2020-2024 | Collagenase Santyl |
| Horizon Therapeutics Plc | $142.10 | 2019-2023 | Krystexxa |
| Paragon 28, INC. | $131.58 | 2023 | Portfolio |
| Biotissue Holdings INC. | $108.38 | 2023 | |
| Integra Lifesciences Corporation | $91.62 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bayer Healthcare Pharmaceuticals INC. | $84.08 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $80.75 | 2019-2024 | Jublia |
| Glenmark Therapeutics INC. | $75.00 | 2019 | |
| Alnylam Pharmaceuticals INC. | $67.55 | 2023-2024 | Amvuttra |
| Baxter Healthcare | $66.77 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $59.72 | 2021 | |
| Depuy Synthes Sales INC. | $56.72 | 2025 | Na |
| Zimmer Biomet Holdings, INC. | $51.73 | 2020 | |
| Organogenesis INC. | $48.07 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $47.50 | 2022-2023 | Xarelto |
| Sandoz INC. | $43.47 | 2019 | |
| Micromed INC | $40.31 | 2021 | |
| Ibsa Pharma INC. | $39.34 | 2025 | Flector, Licart, Tirosint |
| Wright Medical Technology, INC. | $35.50 | 2019 | |
| Janssen Scientific Affairs, LLC | $34.77 | 2023 | Xarelto |
| Acell, INC. | $34.24 | 2019-2020 | |
| Edwards Lifesciences Corporation | $31.87 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.87 | 2021 | |
| Melinta Therapeutics, LLC | $28.18 | 2019 | |
| Abbvie INC. | $26.80 | 2024 | |
| Celularity INC. | $24.55 | 2020 | |
| Lilly USA, LLC | $23.25 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.86 | 2024 | Xifaxan |
| Inspire Medical Systems, INC. | $22.62 | 2024 | Inspire |
| Abbott Laboratories | $17.32 | 2025 | Eterna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.72 | 2025 | Jardiance |
| Misonix INC | $14.35 | 2021 | |
| Medimetriks Pharmaceuticals, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Sanandaji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.